Carol Anne Braun

US Patent:

57183619, Feb 17, 1998

Filed:

Nov 21, 1995

Appl. No.:

8/561571

Inventors:

Carol Jill Braun - LaGrangeville NY
James Howard Covell - Poughkeepsie NY

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

H01L 2160

US Classification:

228 563

Abstract:

The present invention relates generally to a new apparatus and method for molding metallic materials, such as, for example, solder. More particularly, the invention encompasses an apparatus that is used to form metallic interconnections, such as, for example, solder connections, such as, BGA (Ball Grid Array) or CGA (Column Grid Array) in a mold for later use to electrically or mechanically connect two devices, such as, for example, semiconductor devices. A method for forming the metallic connections that are used to electrically or mechanically connect two devices, such as, for example, semiconductor devices is also disclosed. However, these metallic interconnections in a mold could also be used to form other structures, such as, for example, heat sinks with fins, etc.

US Patent:

57183678, Feb 17, 1998

Filed:

Nov 21, 1995

Appl. No.:

8/562079

Inventors:

James Howard Covell - Poughkeepsie NY
Carol Jill Braun - LaGrangeville NY

Assignee:

International Business Machines Corporation - Armonk NY

International Classification:

H01L 21441

US Classification:

228254

Abstract:

The present invention relates generally to a new mold transfer apparatus and method. More particularly, the invention encompasses an apparatus that is used to form metallic interconnections, such as, for example, solder connections, such as, solder balls or solder columns, using a mold that is already filled with transferable metallic material. However, these metallic interconnections in a mold could also be used to form other structures, such as, for example, heat sinks with fins, etc.

US Patent:

20210283106, Sep 16, 2021

Filed:

May 31, 2021

Appl. No.:

17/335016

Inventors:

- Baltimore MD, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US

Assignee:

Lupin Inc. - Baltimore MD

International Classification:

A61K 31/4164
A61K 45/06
C07D 233/94
A61K 31/565
A61K 31/567
A61K 9/00
A61K 9/16
A61K 9/50

Abstract:

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

US Patent:

20200306228, Oct 1, 2020

Filed:

Jun 15, 2020

Appl. No.:

16/901739

Inventors:

- Baltimore MD, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US
Richard HOLL - Somerset NJ, US

Assignee:

LUPIN INC. - Baltimore MD

International Classification:

A61K 31/4164
A61K 45/06
C07D 233/94
A61K 31/565
A61K 31/567
A61K 9/00
A61K 9/16
A61K 9/50

Abstract:

Method of treating trichomoniasis in a subject in need thereof involving administering to the subject a therapeutically effective amount of secnidazole in a microgranule formulation, wherein the microgranule formulation comprises a plurality of microgranules having a volume-weighted particle size distribution within a microgranule population, wherein the volume-weighted particle size distribution as measured from a representative sample of the microgranule population comprises (a) 10% of the microgranule population having a volume-weighted particle size about no less than 470 micrometers; (b) 50% of the microgranule population having a volume-weighted particle size between about no less than 640 micrometers and about no more than 810 micrometers; (c) 90% of the microgranule population having a volume-weighted particle size about no more than 1170 micrometers; or (d) a combination thereof, which can include some or all of (a) through (c) above.

US Patent:

20200289470, Sep 17, 2020

Filed:

Jun 2, 2020

Appl. No.:

16/890526

Inventors:

- Baltimore MD, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US

Assignee:

LUPIN INC. - Baltimore MD

International Classification:

A61K 31/4164
A61K 45/06
C07D 233/94
A61K 31/565
A61K 31/567
A61K 9/00
A61K 9/16
A61K 9/50

Abstract:

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of trichomoniasis in a subject in need thereof.

US Patent:

20200206192, Jul 2, 2020

Filed:

Mar 12, 2020

Appl. No.:

16/817246

Inventors:

- Baltimore MD, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US
Richard HOLL - Somerset NJ, US

Assignee:

LUPIN INC. - Baltimore MD

International Classification:

A61K 31/4164
A61K 9/50
A61K 9/16
A61K 9/00
A61K 31/567
A61K 31/565
C07D 233/94
A61K 45/06

Abstract:

Method of treating bacterial vaginosis in a subject in need thereof involving administering to the subject a therapeutically effective amount of secnidazole in a microgranule formulation, wherein the microgranule formulation comprises a plurality of microgranules having a volume-weighted particle size distribution within a microgranule population, wherein the volume-weighted particle size distribution as measured from a representative sample of the microgranule population comprises (a) 10% of the microgranule population having a volume-weighted particle size about no less than 470 micrometers; (b) 50% of the microgranule population having a volume-weighted particle size between about no less than 640 micrometers and about no more than 810 micrometers; (c) 90% of the microgranule population having a volume-weighted particle size about no more than 1170 micrometers; or (d) a combination thereof, which can include some or all of (a) through (c) above.

US Patent:

20200038372, Feb 6, 2020

Filed:

Sep 27, 2019

Appl. No.:

16/586372

Inventors:

- NEWARK NJ, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US

Assignee:

SYMBIOMIX THERAPEUTICS, LLC - NEWARK NJ

International Classification:

A61K 31/4164
A61K 45/06
C07D 233/94
A61K 31/565
A61K 31/567
A61K 9/00
A61K 9/16
A61K 9/50

Abstract:

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).

US Patent:

20200022958, Jan 23, 2020

Filed:

Sep 27, 2019

Appl. No.:

16/586339

Inventors:

- NEWARK NJ, US
David PALLING - Glen Ridge NJ, US
Carol J. BRAUN - Ellicott City MD, US

Assignee:

SYMBIOMIX THERAPEUTICS, LLC - NEWARK NJ

International Classification:

A61K 31/4164
A61K 45/06
C07D 233/94
A61K 31/565
A61K 31/567
A61K 9/00
A61K 9/16
A61K 9/50

Abstract:

Embodiments are directed to a secnidazole formulations and the use of a secnidazole formulation for the treatment of bacterial vaginosis (BV).